Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P-3074 (Topical Finasteride) in Androgenetic Alopecia
NCT03004469Phase 3Completed
- Sponsor
- Polichem
- Start
- Aug 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of AD-3031 in androgenetic alopecia (AGA), sponsored by Polichem. Started Aug 2016; status: completed.
02
Drugs
AD-3031
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT03004469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03004469.